Pacific Biosciences, a private company developing a disruptive 
      technology platform for real-time detection of biological events at 
      single molecule resolution, today announced the launch of a partner 
      program designed to work with best-in-class organizations providing 
      complementary solutions to its Single Molecule Real Time (SMRT™) DNA 
      sequencing system. The program will help customers rapidly and easily 
      adopt its third-generation DNA sequencing solution into their discovery 
      programs.
    
“The overwhelming response 
      from companies wanting to partner with us is extremely validating as we 
      stand on the verge of introducing a breakthrough technology to redefine 
      DNA sequencing. We look forward to continuing to champion collaboration 
      in the industry.”
    
      “We have thought carefully about what it takes to successfully introduce 
      a new generation of technology to the marketplace, and putting in place 
      an entire ecosystem of complementary solutions has been one of our 
      strategies from the beginning,” said Hugh Martin, Chairman and Chief 
      Executive Officer of Pacific Biosciences. “The overwhelming response 
      from companies wanting to partner with us is extremely validating as we 
      stand on the verge of introducing a breakthrough technology to redefine 
      DNA sequencing. We look forward to continuing to champion collaboration 
      in the industry.”
    
    
      Pacific Biosciences has created an open and extensible system in order 
      to encourage innovation across the industry. To support a whole product 
      solution with the commercial launch of the SMRT system in the second 
      half of 2010, the company has developed a formal partner program 
      designed for companies providing consumables, automation systems, 
      complementary instrumentation, services, and supporting software and 
      hardware. The eleven initial members of the program are:
    
    
      - 
        Agilent Technologies, a technology leader in communications, 
        electronics, life sciences and chemical analysis, provider of the 
        SureSelect Target Enrichment System
      
 
      - 
        Amazon Web Services, a global leader in cloud-based computing, 
        provider of the Amazon Elastic Compute Cloud (Amazon EC2) and Amazon 
        Simple Storage Service (Amazon S3)
      
 
      - 
        BioTeam, a solutions architect with expertise in integrating 
        high-performance computing and storage systems, cloud technologies, 
        wiki-based data management systems and DNA sequencing platforms
      
 
      - 
        Caliper Life Sciences, an industry leader in tools and services for 
        drug discovery and life sciences research, provider of the LabChip XT® 
        fractionation size selection technology
      
 
      - 
        CLC bio, a global leader in bioinformatics, providing high-throughput 
        sequencing analysis solutions such as CLC Genomics Workbench and CLC 
        Genomics Server
      
 
      - 
        Fluidigm, the leading supplier of innovative systems based on 
        integrated fluidic circuit technology, and provider of the Fluidigm 
        Access Array™ System for targeted enrichment applications
      
 
      - 
        GenoLogics, a leading provider of informatics solutions for life 
        sciences, which offers Geneus™, an adaptable and rapidly scalable 
        next-gen sequencing LIMS and data management system for streamlining 
        end-to-end sample and data tracking
      
 
      - 
        GenomeQuest, a leader in sequence data management (SDM), provider of 
        the GenomeQuest SDM platform and cloud services
      
 
      - 
        Geospiza, an industry leader in cloud computing solutions for genetic 
        analysis, which is focused on delivering best practices to the market 
        through its GeneSifter™ Lab and Analysis products
      
 
      - 
        NuGEN Technologies, a leader in reagents for genomic sample 
        preparation, provider of the Ovation® whole genome amplification, 
        whole transcriptome amplification, and RNA-Seq kits
      
 
      - 
        RainDance Technologies, the leader in microdroplet-based solutions 
        enabling single molecule and single cell analysis of molecular, 
        biological and physiological events, provider of the RDT 1000 
        system and sequence enrichment kits
      
 
    
    
      “This is a dynamic field, and we’re pleased to work with innovators like 
      PacBio,” said Chris Grimley, Agilent’s Senior Director of Genomics 
      Marketing. “We look forward to working together to develop new 
      scientific applications that will benefit tremendously from the 
      introduction of PacBio’s third-generation DNA sequencing technology and 
      the efficiencies enabled by our targeted sequencing platform.”
    
    
      Members of the partner program will receive access to information and 
      development tools, APIs, protocols, and potential co-marketing 
      opportunities depending on the specific terms of the partnership. In 
      some cases, Pacific Biosciences will engage in co-development agreements 
      to bring complementary solutions to market.
    
    
      “Pacific Biosciences is changing the game with the real-time streaming 
      of its sequencing data and the granularity in which it is delivered,” 
      said Rob Arnold, President, Geospiza. “This revolution is an ideal match 
      for a cloud-based computing service and we look forward to working with 
      PacBio to meet the informatics needs associated with this new era of DNA 
      sequencing technology.”